Indraprastha Medical Corporation Limited Share Price

Equities

INDRAMEDCO

INE681B01017

Healthcare Facilities & Services

Delayed NSE India S.E. 12:43:47 26/04/2024 BST 5-day change 1st Jan Change
262.2 INR -1.06% Intraday chart for Indraprastha Medical Corporation Limited +12.70% +52.04%

Financials

Sales 2022 8.88B 107M 8.51B Sales 2023 10.99B 132M 10.52B Capitalization 7.06B 84.74M 6.77B
Net income 2022 586M 7.03M 561M Net income 2023 862M 10.34M 826M EV / Sales 2022 0.53 x
Net cash position 2022 607M 7.28M 581M Net cash position 2023 1.24B 14.84M 1.19B EV / Sales 2023 0.53 x
P/E ratio 2022
9.14 x
P/E ratio 2023
8.2 x
Employees 2,947
Yield 2022
4.28%
Yield 2023
3.89%
Free-Float 44.33%
More Fundamentals * Assessed data
Dynamic Chart
ICRA Keeps AA Rating on Indraprastha Medical's Bank Financing MT
HDFC Bank Sells 3% Stake in Indraprastha Medical for INR555 Million MT
Indraprastha Medical Corporation Limited Announces Resignation of Vikram Bhat as Non-Executive Director CI
Indraprastha Medical Corporation Limited Announces Cessation of Independent Director CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 30, 2023 CI
India to probe Apollo Hospital Delhi's alleged links to 'cash for kidneys' scandal RE
India's Apollo Hospitals' operator rejects allegation of illegal kidney transplants RE
Indraprastha Medical Corporation Limited Announces Cessation of Jasmine Shah as Non-Executive Director & Chairman CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Indraprastha Medical Corporation Limited Announces Resignation of Udit Prakash Rai as Non-Executive - Non-Independent Director CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Indraprastha Medical Corporation Limited Recommends Dividend for the Financial Year 2022-23 CI
ICRA Gives AA Rating to Indraprastha Medical's Bank Financing MT
More news
1 day-1.06%
1 week+12.70%
Current month+53.02%
1 month+53.02%
3 months+54.69%
6 months+63.52%
Current year+52.04%
More quotes
1 week
255.50
Extreme 255.5
282.80
1 month
173.35
Extreme 173.35
282.80
Current year
154.50
Extreme 154.5
282.80
1 year
81.90
Extreme 81.9
282.80
3 years
52.05
Extreme 52.05
282.80
5 years
28.00
Extreme 28
282.80
10 years
28.00
Extreme 28
282.80
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Compliance Officer 53 23/08/20
Members of the board TitleAgeSince
Director/Board Member 92 15/03/88
Director/Board Member 61 23/08/20
Director/Board Member 65 30/08/05
More insiders
Date Price Change Volume
26/04/24 262.2 -1.06% 810,527
25/04/24 265 -1.01% 386,265
24/04/24 267.7 -3.10% 652,187
23/04/24 276.2 +12.66% 2,711,250
22/04/24 245.2 +5.39% 1,591,543

Delayed Quote NSE India S.E., April 26, 2024 at 12:43 pm

More quotes
Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. The Company provides various services, such as in-patients, out-patients and clinical services. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. Indraprastha Apollo Hospitals has various specialties, such as anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics and gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, ophthalmology, plastic and reconstructive surgery, respiratory and sleep medicine, rheumatology, spine surgery, urology and andrology.
More about the company
  1. Stock Market
  2. Equities
  3. INDRAMEDCO Stock